NeuroZone
Europe, Lombardia, Italy, Milan
Description
unctional service company supporting drug discovery and research projects in the fields of inflammation and age-related pathologies
Investor Profile
NeuroZone has made 2 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series B (50%)
- Series A (50%)
Country Focus
- Italy (100%)
Industry Focus
- Biotechnology
- Health Diagnostics
- Life Science
- Medical Device
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
